FDA Extends Period for Comments on Limit for Carcinogen in Smokeless Tobacco

The Food and Drug Administration is extending until July 10 the period for comments on its proposal to establish a limit on N-nitrosonornicotine (NNN) in finished smokeless tobacco products, it said (here). The proposed limit would apply to smokeless tobacco products manufactured, imported, distributed or sold beginning three years after the publication date of the final rule (see 1701200031). Comments were originally due April 10.